Vascepa is a prescription medication that contains the active ingredient icosapent ethyl. It is used to treat high levels of triglycerides, a type of fat in the blood, in adults. According to the drug patent watch [1], Vascepa is currently the only FDA-approved prescription medication for reducing triglyceride levels in adults.

A study published in the Journal of Clinical Lipidology [2] compared the efficacy of Vascepa with other treatments for reducing triglyceride levels. The study found that Vascepa was more effective than fenofibrate, a commonly prescribed medication for high triglycerides. Additionally, Vascepa was found to be more effective than omega-3 fatty acid supplements, which are often used as a dietary supplement to lower triglycerides.

According to Medical News Today [3], Vascepa has been shown to reduce the risk of cardiovascular events such as heart attack and stroke in patients with high triglyceride levels. The drug has also been found to be well-tolerated and safe for long-term use.

In summary, Vascepa is a prescription medication that is more effective than other treatments such as fenofibrate and omega-3 fatty acid supplements for reducing triglyceride levels. It has also been shown to reduce the risk of cardiovascular events and is considered safe for long-term use.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671468/
[3] https://www.medicalnewstoday.com/articles/drugs-vascepa